本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Fractyl Health

0.5650
-0.0466-7.62%
盤後0.5642-0.0008-0.14%19:46 EDT
成交量:174.08萬
成交額:100.36萬
市值:8,963.67萬
市盈率:-0.50
高:0.6140
開:0.6000
低:0.5600
收:0.6116
52周最高:2.45
52周最低:0.3772
股本:1.59億
流通股本:1.28億
量比:1.53
換手率:1.36%
股息:- -
股息率:- -
每股收益(TTM):-1.1193
每股收益(LYR):-1.8600
淨資產收益率:-778.33%
總資產收益率:-74.57%
市淨率:-53.84
市盈率(LYR):-0.30

資料載入中...

公司資料

公司名字:
Fractyl Health
交易所:
NASDAQ
成立時間:
2010
員工人數:
100
公司地址:
3 Van de Graaff Drive,Suite 200,Burlington,Massachusetts,United States
郵編:
01803
電話:
傳真:
- -
簡介:
Fractyl Health, Inc.於2010年8月30日在特拉華州註冊成立。該公司是一家臨床階段的代謝療法公司,專註於開發治療肥胖和2型糖尿病的新方法。其主要候選產品Revita DMR系統旨在重塑十二指腸黏膜,以解決代謝疾病的根本原因。

董事

名稱
職位
Ajay Royan
Director and Chairman
Harith Rajagopalan
Chief Executive Officer and Director
Amy W. Schulman
Director
Christopher Thompson
Director
Clive Meanwell
Director
Ian Sheffield
Director
Kelly Barnes
Director
Marc Elia
Director
Samuel Conaway
Director
William W. Bradley
Director

股東

名稱
職位
Harith Rajagopalan
Chief Executive Officer and Director
Lara Smith Weber
Chief Financial Officer and Principal Accounting Officer
Jay D. Caplan
Co-Founder, President and Chief Product Officer
Sarah Toomey
General Counsel and Corporate Secretary
Timothy Kieffer
Chief Scientific Officer